Company Profile

Xvivo Perfusion (OTC: XVIPY)
6:02 PM UTC, 07/02/24
Last: $9.81 Change: -0.56 %Change: -5.45% Volume: 100
Detailed Quote
Open: $ 9.81   Volume: 100
High: $ 9.81   Yield(%) 0.00
Low: $ 9.81   P/E Ratio (ttm): 127.20
Dividend ($): n/a   Market Cap ($): 1.21B
EPS ($) 0.08   Shares Out: 126.00M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -7.06
% Price Change (last 13 weeks): 54.65
% Price Change (last 26 weeks): 18.47
% Price Change (last 52 weeks): 41.49
% Price Change (year to date): 17.69
Management Effectiveness
Return on Equity (%): 5.24
Return on Assets (%): 4.50
Return on Invested Capital (%): 0.59
Profitability
Gross Profit Margin (%): 69.77
Net Profit Margin (%): 15.37
Operating Profit Margin (%): 6.44
Price & Volume
50-day Moving Average: $n/a
200-day Moving Average: $n/a
Avg. Daily Vol. (last 50 days): n/a
Avg. Daily Vol. (last 200 days): n/a
52-wk high: $10.38
52-wk low: $6.24
Bid: $n/a
Ask: $n/a
Company Information
Xvivo Perfusion AB is a medical technology company. It involves in developing and marketing solutions and systems for assessing the usability of organs, and maintaining organs in good condition outside the body pending transplantation. Its products include XPS, XPS Disposable Kit, Steen Solution, Organ Chamber, Lung Cannula Set, Perfadex and Silicone Tubing Set. It operates through the Durable Goods and Non-Durable Goods segments. The Durable Goods segment includes sales and rental revenues from machines. The Non-Durable Goods segment covers sales of goods and services that are not durable goods. The company was founded by Magnus Nilsson on December 17, 1998 and is headquartered in Gothenburg, Sweden.
Xvivo Perfusion
Mässans gata 10
Gothenburg VG 412 51

Phone: 46.31.788.21.50
Fax: 46.31.788.21.69
http://www.xvivoperfusion.com
Per Share Data
Earnings (1year) ($): 0.08
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): 127.20
Book Value ($): 1.53
Cash Flow ($): 0.09
Valuation Ratios
Price/Earnings (x): 127.20
Price/Sales (x): 17.39
Price/Book (x): 5.34
Price/Cash Flow (x): 224.48
Financial Strength
Quick Ratio (x): 5.09
Current Ratio (x): 6.14
LT Debt/Equity (x): 1.09
Total Debt/Equity (x): 1.62



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.